Age, Biography and Wiki

Adrian Krainer (scientist) (Adrian Roberrt Krainer) was born on 1958 in Montevideo, Uruguay, is a Uruguayan neuroscientist. Discover Adrian Krainer (scientist)'s Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 66 years old?

Popular As Adrian Roberrt Krainer
Occupation N/A
Age 66 years old
Zodiac Sign
Born 1958
Birthday 1958
Birthplace Montevideo, Uruguay
Nationality Uruguay

We recommend you to check the complete list of Famous People born on 1958. He is a member of famous with the age 66 years old group.

Adrian Krainer (scientist) Height, Weight & Measurements

At 66 years old, Adrian Krainer (scientist) height not available right now. We will update Adrian Krainer (scientist)'s Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Who Is Adrian Krainer (scientist)'s Wife?

His wife is Kate Krainer

Family
Parents Not Available
Wife Kate Krainer
Sibling Not Available
Children 3

Adrian Krainer (scientist) Net Worth

His net worth has been growing significantly in 2023-2024. So, how much is Adrian Krainer (scientist) worth at the age of 66 years old? Adrian Krainer (scientist)’s income source is mostly from being a successful . He is from Uruguay. We have estimated Adrian Krainer (scientist)'s net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income

Adrian Krainer (scientist) Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

Adrian Robert Krainer is a Uruguayan-American biochemist and molecular geneticist known for his research into RNA gene-splicing.

He helped create a drug for patients with spinal muscular atrophy.

Krainer holds the St. Giles Foundation Professorship at Cold Spring Harbor Laboratory in Laurel Hollow, New York.

Krainer was born in Montevideo, Uruguay to a Jewish family of Hungarian and Romanian descent.

He has one older brother, who is a chemical engineer.

His father did forced labor for two years in a Romanian labor camp (Ferma Alba) during World War II.

After the war, his father's original surname, Kreiner changed to Krainer due to a clerical error when he was a refugee in Italy.

His parents owned a small leather business in Montevideo.

Krainer attended a private bilingual French-Spanish elementary school.

He later attended a public school for two years before completing his pre-college education with four years at a private Spanish-Hebrew school.

Krainer lived through political unrest during his teenage years, including urban guerrilla and military dictatorship.

1981

Krainer received a full scholarship from Columbia University and completed a Bachelor of Arts degree in Biochemistry in 1981.

He graduated cum laude and Phi Beta Kappa.

1986

In 1986, he earned a Doctor of Philosophy degree in biochemistry from Harvard University.

From 1986 to 1989, Krainer conducted postdoctoral research as the first Cold Spring Harbor Fellow at the Cold Spring Harbor Laboratory.

1989

Krainer worked as an assistant professor from 1989 to 1990, Associate Professor from 1990 to 1994, and Professor since 1994.

Krainer is a faculty member of the graduate programs in Genetics, Molecular and Cellular Biology, and Molecular Genetics and Microbiology at State University of New York, Stony Brook.

Krainer holds the St. Giles Foundation Professorship at Cold Spring Harbor Laboratory.

His former students include Ewan Birney.

Krainer is a co-founder and Director of Stoke Therapeutics, based in Bedford, MA.

In 2021 Krainer received the Wolf Prize in Medicine.

2019

In 2019 he was awarded a Breakthrough Prize in Life Sciences for his contributions to the understanding of the RNA gene-splicing process and, in collaboration with fellow Prize Laureate Dr. Frank Bennet of Ionis Pharmaceuticals, the development of medical interventions that target the RNA-splicing process, including Spinraza, which is the first treatment for the genetic disorder Spinal Muscular Atrophy. Other honors include:

Krainer's father and maternal grandparents were Holocaust refugees.

He has three children, Emily, Andrew, and Brian.

His wife, Kate Krainer, is a plant geneticist.